Researchers at the Germans Trias i Pujol Foundation will use Qlucore's Omics Explorer software to support their studies of a number of diseases, including inflammatory bowel disease, Crohn's disease, and ulcerative colitis, Qlucore announced last week.
IGTP is a biomedical research institute based in Badalona, Spain, near Barcelona. Eli Pedrosa Tapias, IGTP's technical supervisor, said in a statement that the addition of Omics Explorer will make the institute's research "much more efficient … by providing our researchers with valuable data that they can interpret very quickly."
Carl-Johan Ivarsson, president of Qlucore, said IGTP's adoption of Omics Explorer is a "very powerful endorsement" for the four-year-old software company.
Omics Explorer relies on a "core engine" that visualizes data in three dimensions, helping the user to "identify hidden structures and patterns," according to its website. Qlucore claims its software can aid users in the analysis of array and RT-PCR-based gene expression; array-based DNA methylation; array-, gel-, and mass spectrometry-based protein expression; and RNA-seq.
The company's first offering was called Qlucore Gene Expression Explorer 1.0, but the name was later changed to Omics Explorer to reflect its expanded capabilities. Since its initial release in 2007, the software has been updated to achieve compatibility with a number of array platforms, including those sold by Affymetrix and Agilent Technologies.
Lund, Sweden-based Qlucore serves European customers like IGTP directly. The company earlier this month inked a distribution pact with Beijing-based SinoGenoMax to reach Asian customers (BAN 9/6/2011).
Further details of Qlucore's recent deal with IGTP were not discussed.